C-Reactive protein and cardiac allograft vasculopathy (Q57652958)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906977%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

C-Reactive protein and cardiac allograft vasculopathy. is inflammation the critical link? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906977%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906977%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Hector O Ventura

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906977%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906977%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906977%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906977%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906977%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

483-485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906977%20AND%20SRC:MED&resulttype=core&format=json

Circulating markers of inflammation for vascular risk prediction: are they ready for prime time

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Profiles in cardiology. Rudolph Virchow and cellular pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Cardiac allograft vasculopathy: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Crossing the vasculopathy bridge from morphology to therapy: a single center experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

The status of cardiac transplantation, 1975

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Transplant coronary artery disease: a novel model independent of cellular alloimmune response

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Immunohistochemical model to predict risk for coronary artery disease and failure in heart transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Effect of immunosuppressive regimen on novel markers of atherothrombosis in heart transplantation: homocysteine, c-reactive protein, and mean platelet volume

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900646-6

7 January 2021

10.1016/S0735-1097(03)00646-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906977%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference